Based on the single-cell RNA-sequencing analysis of CSF in five patients with breast cancer and NSCLC, a higher expression of the iron-binding protein lipocalin-2 and its receptor, SCL22A17, was identified in cancer cells as a result of the macrophage cytokine response [90]. The gene discussed is LCN2; the disease is cancer.